Literature DB >> 210874

Differences in dihydroergotamine antagonism of glucose release by catecholamines, glucagon and adenosine 3',5'-monophosphate in rabbit liver slices.

P S Chan, S Ellis, E Mühlbachová.   

Abstract

1 Quantitative studies were made on the glucose release from rabbit liver slices in vitro induced by a range of concentrations of (-)-adrenaline (Ad), (-)-isoprenaline (Iso), glucagon and adenosine 3',5'-monophosphate (cyclic AMP) in the presence and absence of several concentrations of dihydroergotamine (DHE). 2 DHE (3.16 X 10(-6) M) shifted the Ad log concentration-response (LCR) curve to the right and also reduced the maximum response; at a higher concentration (3.16 x 10(-5) M) it produced a greater shift to the right of the LCR curve and caused a reduction in the slope and a larger depression of the maximal responses. The LCR curve to Iso was similarly affected by this higher concentration of DHE. 3 DHE (1 X 10(-5) M) produced no significant effect on the LCR curves of glucagon or cyclic AMP and even at 1 x 10(-4) M DHE caused only a slight depression of the maximal responses to both agonists without any modification of the lower major portions of the curves. 4 These data indicate a selective antagonism by DHE at the rabbit liver adrenoceptor and, since the maximal responses to catecholamines were depressed by a lower concentration of DHE than was required to produce a slight depression of the responses to glucagon and cyclic AMP, the antagonism of DHE against catecholamines does not appear to be at a site beyond the formation of cyclic AMP, but rather at a site more intimately related to the adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210874      PMCID: PMC1668120          DOI: 10.1111/j.1476-5381.1978.tb17271.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  THE EFFECTS OF ADRENERGIC BLOCKING AGENTS AND THEOPHYLLINE ON 3',5'-AMP-INDUCED HYPERGLYCEMIA.

Authors:  G NORTHROP; R E PARKS
Journal:  J Pharmacol Exp Ther       Date:  1964-07       Impact factor: 4.030

Review 2.  THE ACTION OF EPINEPHRINE AND THE ROLE OF THE ADENYL CYCLASE SYSTEM IN HORMONE ACTION.

Authors:  E W SUTHERLAND; I OYE; R W BUTCHER
Journal:  Recent Prog Horm Res       Date:  1965

3.  The receptors for epinephrine and norepinephrine (adrenergic receptors).

Authors:  R F FURCHGOTT
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

4.  An analysis of adrenergic blocking activity.

Authors:  B LEVY; R P AHLQUIST
Journal:  J Pharmacol Exp Ther       Date:  1961-08       Impact factor: 4.030

5.  The assay of glucagon and epinephrine with use of liver homogenates.

Authors:  J BERTHET; E W SUTHERLAND; T W RALL
Journal:  J Biol Chem       Date:  1957-11       Impact factor: 5.157

6.  Pharmacologic differentiation between epinephrine- and HGF-hyperglycemias: application in analysis of cobalt-hyperglycemia.

Authors:  S ELLIS; H L ANDERSON; M C COLLINS
Journal:  Proc Soc Exp Biol Med       Date:  1953-11

7.  Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver.

Authors:  F MURAD; Y M CHI; T W RALL; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

8.  Blockade of epinephrine-induced hyperglycemia.

Authors:  S C HARVEY; C Y WANG; M NICKERSON
Journal:  J Pharmacol Exp Ther       Date:  1952-03       Impact factor: 4.030

9.  Quantitative studies of glucose release from rabbit liver slices induced by catecholamines and their antagonism by propranolol and phentolamine.

Authors:  E Mühlbachová; P S Chan; S Ellis
Journal:  J Pharmacol Exp Ther       Date:  1972-09       Impact factor: 4.030

Review 10.  Adenyl cyclase as an adrenergic receptor.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.